Latest news
Zanubrutinib Improved IgG4-Related Disease Outcomes - EMJEMJ · Wed, 05 Aug 2026 14:02:12 GMTABLi Therapeutics Announces Outcomes from its Parkinson’s-related Biomarker Study Demonstrating Modification of Human Disease with Risvodetinib - The Manila TimesThe Manila Times · Tue, 04 Aug 2026 12:19:46 GMT